Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.009
Neutral
RSI(14)
46.644
Neutral
STOCH(KDJ)(9,3,3)
59.693
Sell
ATR(14)
0.182
Low Volatility
CCI(14)
33.655
Neutral
Williams %R
57.956
Sell
TRIX(12,20)
-0.151
Sell
StochRSI(14)
0.000
Sell
Search
Nasus Pharma Ltd
NSRXAdd to Watchlist
3.030USD
+0.020+0.63%
Close 07-31 16:00（ET）Quotes delayed by 15 min
35.48MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.63%
5 Days
-2.88%
1 Month
-13.43%
6 Months
-47.21%
Year to Date
-66.89%
1 Year
0.00%
Key Figures
2.960Open
3.220High
5.74KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.06%Turnover Ratio
3.180Prev. Close
2.960Low
9.35KTurnover
LossP/E Static
-6.36P/B
0.00%Div Yield TTM
--ROA
9.99052wk High
0.35Volume Ratio
-1.53KNet Profit
9.06MShares
-0.7311EPS TTM
--Beta
--ROE
1.98052wk Low
8.18%Amplitude
--Gross Margin
35.48MMarket Cap
-1.39Reward/Risk
6.87%Risk Rate
Nasus Pharma Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
2
analysts
Buy
Current Rating
19.667
Target Price
+512.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Nasus Pharma Ltd
NSRX
2
Amgen Inc
AMGN
38
Biogen Inc
BIIB
38
Eli Lilly and Co
LLY
34
AbbVie Inc
ABBV
33
Pfizer Inc
PFE
32
1
2
3
...
32
Indicators
Moving Average
Indicators
Value
Direction
MA5
3.108
Sell
MA10
3.070
Sell
MA20
3.078
Sell
MA50
3.118
Sell
MA100
2.993
Buy
MA200
4.709
Sell
Nasus Pharma Ltd Info
Nasus Pharma Ltd is an Israel-based pharmaceutical company. The Company conducts ins business activities as a pharmaceutical preparation and intranasal powder-based drug delivery systems manufacturer. Its microsphere technology enables rapid, non-invasive administration of medications for conditions such as anaphylaxis and opioid overdose among others. Nasus Pharma Ltd's formulations are designed for relatively fast absorption, ease of use, and effectiveness in critical situations (such as emergency use). The Company's products predominantly aim to improve access to life-saving treatments by allowing easy administration by caregivers or non-professionals, as well as medical doctors and emergency nurses.
Ticker SymbolNSRX
CompanyNasus Pharma Ltd
CEOTeleman (Dan)
Websitehttps://www.nasuspharma.com
Shareholders
Related Instruments
-0.53%
+0.27%
-2.51%
+0.32%
-1.45%
-0.92%
-0.64%
-0.82%
-8.79%
+0.52%
+0.68%
-0.95%
-0.71%
+0.44%
-1.08%
+3.29%
0.00%
-0.90%
+1.30%
-2.15%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Nasus Pharma Ltd (NSRX)?
The current price of Nasus Pharma Ltd (NSRX) is 3.20.
What is the symbol of Nasus Pharma Ltd?
The ticker symbol of Nasus Pharma Ltd is NSRX.
What is the 52-week high of Nasus Pharma Ltd?
The 52-week high of Nasus Pharma Ltd is 9.99.
What is the 52-week low of Nasus Pharma Ltd?
The 52-week low of Nasus Pharma Ltd is 1.98.
What is the market capitalization of Nasus Pharma Ltd?
The market capitalization of Nasus Pharma Ltd is 28.99M.
Is Nasus Pharma Ltd (NSRX) currently rated as Buy, Hold, or Sell?
According to analysts, Nasus Pharma Ltd (NSRX) has an overall rating of Buy, with a price target of 19.67.
What is the Earnings Per Share (EPS TTM) of Nasus Pharma Ltd (NSRX)?
The Earnings Per Share (EPS TTM) of Nasus Pharma Ltd (NSRX) is -0.73.